Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Daily G-CSF (filgrastim) and a Single Dose Of Pegylated G-CSF (pegfilgrastim) After Chemotherapy Result In Different Kinetics Of Circulating Hematopoetic Progenitors: Implication For Potential Stem Cell Harvesting

Felix Schaub, Birgit Federmann, MD, Lothar Kanz, MD, Robert Möhle, MD

Blood (2013) 122 (21): 4513.

https://doi.org/10.1182/blood.V122.21.4513.4513

Published: 2013

Journal Articles

Delayed Immune Reconstitution After Allogeneic Hematopoietic Cell Transplantation with Yttrium-90 Ibritumomab Tiuxetan-Based Reduced-Intensity Conditioning

Dominik Schneidawind, MD, Sebastian Jendryssek, Birgit Federmann, MD, Christoph Faul, MD, Wichard Vogel, MD, Lothar Kanz, MD, Wolfgang A Bethge, MD

Blood (2012) 120 (21): 4482.

https://doi.org/10.1182/blood.V120.21.4482.4482

Published: 2012

Journal Articles

Reduced-Intensity Conditioning with Fludarabine and Busulfan: Age Has No Negative Impact On Survival

Dominik Schneidawind, MD, Birgit Federmann, MD, Andrea Helwig, Wichard Vogel, MD, Christoph Faul, MD, Lothar Kanz, MD, Wolfgang A Bethge, MD

Blood (2012) 120 (21): 2041.

https://doi.org/10.1182/blood.V120.21.2041.2041

Published: 2012

Journal Articles

KIR Haplotype B Donors but Not KIR-Ligand Mismatch Result in a Reduced Risk of Relapse After Haploidentical Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning and a CD3/CD19 Depleted Graft.

Sebastian Michaelis, cand.med., Markus Mezger, PhD, Martin Bornhauser, MD, Rudolf Trenschel, Gernot Stuhler, MD, Matthias Stelljes, MD, Lutz P Mueller, MD, Herrad Baurmann, MD, Birgit Federmann, MD, Lena Oevermann, MD, Lothar Kanz, MD, Rupert Handgretinger, MD, Wolfgang A. Bethge, MD

Blood (2012) 120 (21): 3101.

https://doi.org/10.1182/blood.V120.21.3101.3101

Published: 2012

Journal Articles

Results of Second or Third Allogeneic Hematopoietic Cell Transplantation As Salvage Therapy for Patients Failing Primary Transplantation

Birgit Federmann, MD, Christoph Faul, MD, Wichard Vogel, MD, Lothar Kanz, MD, Wolfgang A. Bethge, MD

Blood (2011) 118 (21): 4516.

https://doi.org/10.1182/blood.V118.21.4516.4516

Published: 2011

Journal Articles

Allogeneic Hematopoietic Cell Transplantation with FLAMSA-RIC Can Overcome the Poor Prognosis of Primary Refractory or Relapsed AML

Dominik Schneidawind, MD, Birgit Federmann, MD, Christoph Faul, MD, Wichard Vogel, MD, Lothar Kanz, MD, Wolfgang A. Bethge, MD

Blood (2011) 118 (21): 1938.

https://doi.org/10.1182/blood.V118.21.1938.1938

Published: 2011

Journal Articles

Impact of Donor Source and Match on Outcome of Allogeneic Hematopoietic Cell Transplantation with Reduced Intensity Conditioning

Birgit Federmann, MD, Christoph Faul, MD, Wichard Vogel, MD, Lothar Kanz, MD, Wolfgang A. Bethge, MD

Blood (2010) 116 (21): 3539.

https://doi.org/10.1182/blood.V116.21.3539.3539

Published: 2010

Journal Articles

Outcome of Patients Aged ≥60 After Allogeneic Hematopoietec Cell Transplantation: Age Has No Impact on Survival

Birgit Federmann, MD, Christoph Faul, MD, Wichard Vogel, MD, Lothar Kanz, MD, Wolfgang A. Bethge, MD

Blood (2010) 116 (21): 3540.

https://doi.org/10.1182/blood.V116.21.3540.3540

Published: 2010

Journal Articles

Allogeneic Hematopoietic Cell Transplantation in AML: Comparable Results After Matched or Mismatched Unrelated Versus Matched Related Transplantation.

Birgit Federmann, MD, Christoph Faul, MD, Wichard Vogel, MD, Lothar Kanz, MD, Wolfgang Andreas Bethge, MD

Blood (2009) 114 (22): 1199.

https://doi.org/10.1182/blood.V114.22.1199.1199

Published: 2009

Journal Articles

Incidence and Characterization of Taste Disturbances After Allogeneic or Autologous Hematopoietic Stem Cell Transplantation Using Myeloablative or Reduced-Intensity-Conditioning.

Birgit Federmann, MD, Jens Weidmann, Gunnar Blumenstock, MD, Silke Schwarz, Lothar Kanz, MD, Frank Mayer, MD, Wolfgang Andreas Bethge, MD

Blood (2009) 114 (22): 3319.

https://doi.org/10.1182/blood.V114.22.3319.3319

Published: 2009

Journal Articles

Rapid Reconstitution of Human Antibody Secreting Cells After Haploidentical Allogeneic Stem Cell Transplantation.

Martina Steurer, Elke Malenke, Birgit Federmann, MD, Lothar Kanz, MD, Wolfgang Andreas Bethge, MD, Stefan Wirths, MD

Blood (2009) 114 (22): 3682.

https://doi.org/10.1182/blood.V114.22.3682.3682

Published: 2009

Journal Articles

Results of a Phase II Study of Haploidentical Hematopoietic Cell Transplantation (HHCT) in Adults Using Reduced Intensity Conditioning and CD3/CD19-Depleted Grafts: Clinical Outcome and Immune Reconstitution.

Birgit Federmann, MD, Martin Bornhauser, MD, Lambros Kordelas, MD, Dietrich W. Beelen, MD, Gernot Stuhler, MD, Rainer Schwerdtfeger, MD, Matthias Stelljes, MD, Gerhard Behre, MD, Maximilian Christopeit, MD, Christoph Faul, MD, Wichard Vogel, MD, Rupert Handgretinger, MD, Lothar Kanz, MD, Wolfgang Andreas Bethge, MD

Blood (2009) 114 (22): 1203.

https://doi.org/10.1182/blood.V114.22.1203.1203

Published: 2009

Journal Articles

Dose Escalated Radioimmunotherapy with Yttrium-90-Ibritumomab Tiuxetan as Part of a Reduced Intensity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation in Patients with Advanced Aggressive Non-Hodgkin Lymphoma: An Interim Analysis of a Phase I/II Study

Wolfgang A Bethge, MD, Stephanie von Harsdorf, MD, Martin Bornhauser, MD, Dietrich Beelen, MD, Matthias Stelljes, MD, Rainer Schwerdtfeger, MD, Lutz Uharek, Birgit Federmann, MD, Christoph Faul, MD, Wichard Vogel, MD, Helmut Dittmann, MD, Lothar Kanz, MD, Donald Bunjes, MD

Blood (2008) 112 (11): 2995.

https://doi.org/10.1182/blood.V112.11.2995.2995

Published: 2008

Journal Articles

Immune Reconstitution after Haploidentical Hematopoietic Cell Transplantation: Impact of Reduced Intensity Conditioning and CD3/CD19-Depleted Grafts

Birgit Federmann, MD, Matthias Haegele, Christoph Faul, MD, Wichard Vogel, MD, Lothar Kanz, MD, Wolfgang A. Bethge, MD

Blood (2008) 112 (11): 1175.

https://doi.org/10.1182/blood.V112.11.1175.1175

Published: 2008

Journal Articles

Radioimmunotherapy with Yttrium-90-Ibritumomab Tiuxetan as Part of a Reduced Intensity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation in Patients with Advanced Indolent Non-Hodgkin Lymphoma: Interim Analysis of a Phase II Study.

Wolfgang A Bethge, MD, Thoralf Lange, MD, Stephanie von Harsdorf, MD, Martin Bornhauser, MD, Birgit Federmann, MD, Michael Stadler, MD, Lutz Uharek, Stefan Knop, MD, Gerald Wulf, MD, Helmut Dittmann, MD, Christoph Faul, MD, Wichard Vogel, MD, Lothar Kanz, MD, Donald Bunjes, MD

Blood (2008) 112 (11): 1959.

https://doi.org/10.1182/blood.V112.11.1959.1959

Published: 2008

Journal Articles

Haploidentical Allogeneic Hematopoietic Cell Transplantation in Adults Using Reduced Intensity Conditioning and CD3/CD19-Depleted Grafts: Interim Analysis of a Phase I/II Study.

Birgit Federmann, MD, Martin Bornhauser, MD, Dietrich W. Beelen, MD, Gernot Stuhler, MD, Lambros Kordelas, MD, Rainer Schwerdtfeger, MD, Matthias Stelljes, MD, Christoph Faul, MD, Wichard Vogel, MD, Rupert Handgretinger, MD, Lothar Kanz, MD, Wolfgang A. Bethge, MD

Blood (2008) 112 (11): 1962.

https://doi.org/10.1182/blood.V112.11.1962.1962

Published: 2008

NARROW

Daily G-CSF (filgrastim) and a Single Dose Of Pegylated G-CSF (pegfilgrastim) After Chemotherapy Result In Different Kinetics Of Circulating Hematopoetic Progenitors: Implication For Potential Stem Cell Harvesting

Delayed Immune Reconstitution After Allogeneic Hematopoietic Cell Transplantation with Yttrium-90 Ibritumomab Tiuxetan-Based Reduced-Intensity Conditioning

Reduced-Intensity Conditioning with Fludarabine and Busulfan: Age Has No Negative Impact On Survival

KIR Haplotype B Donors but Not KIR-Ligand Mismatch Result in a Reduced Risk of Relapse After Haploidentical Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning and a CD3/CD19 Depleted Graft.

Results of Second or Third Allogeneic Hematopoietic Cell Transplantation As Salvage Therapy for Patients Failing Primary Transplantation

Allogeneic Hematopoietic Cell Transplantation with FLAMSA-RIC Can Overcome the Poor Prognosis of Primary Refractory or Relapsed AML

Impact of Donor Source and Match on Outcome of Allogeneic Hematopoietic Cell Transplantation with Reduced Intensity Conditioning

Outcome of Patients Aged ≥60 After Allogeneic Hematopoietec Cell Transplantation: Age Has No Impact on Survival

Allogeneic Hematopoietic Cell Transplantation in AML: Comparable Results After Matched or Mismatched Unrelated Versus Matched Related Transplantation.

Incidence and Characterization of Taste Disturbances After Allogeneic or Autologous Hematopoietic Stem Cell Transplantation Using Myeloablative or Reduced-Intensity-Conditioning.

Rapid Reconstitution of Human Antibody Secreting Cells After Haploidentical Allogeneic Stem Cell Transplantation.

Results of a Phase II Study of Haploidentical Hematopoietic Cell Transplantation (HHCT) in Adults Using Reduced Intensity Conditioning and CD3/CD19-Depleted Grafts: Clinical Outcome and Immune Reconstitution.

Dose Escalated Radioimmunotherapy with Yttrium-90-Ibritumomab Tiuxetan as Part of a Reduced Intensity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation in Patients with Advanced Aggressive Non-Hodgkin Lymphoma: An Interim Analysis of a Phase I/II Study

Immune Reconstitution after Haploidentical Hematopoietic Cell Transplantation: Impact of Reduced Intensity Conditioning and CD3/CD19-Depleted Grafts

Radioimmunotherapy with Yttrium-90-Ibritumomab Tiuxetan as Part of a Reduced Intensity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation in Patients with Advanced Indolent Non-Hodgkin Lymphoma: Interim Analysis of a Phase II Study.

Haploidentical Allogeneic Hematopoietic Cell Transplantation in Adults Using Reduced Intensity Conditioning and CD3/CD19-Depleted Grafts: Interim Analysis of a Phase I/II Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only